Annual sales were KRW 22.7 billion in 2022, KRW 18.7 billion in 2023 (down 17.7% year on year), KRW 21.4 billion in 2024 (up 14.3%) and KRW 23.3 billion in 2025 (up 9.0%). Sales rose in 2024 and 2025 after the 2023 low, and 2025 was the largest year of 2022–2025.
Operating profit of KRW 1.85 billion in 2022 turned into an operating loss of KRW 4.24 billion in 2023, then returned to profit at KRW 1.18 billion in 2024. Operating profit fell 75.2% to KRW 294 million in 2025, and the operating margin went from 8.1% to -22.7%, then 5.5%, then 1.3%.
The 2025 decline was attributed in the company's disclosure to higher raw material costs and higher R&D expenses.
Net profit attributable to controlling shareholders was KRW 7.01 billion in 2022, the largest year, then KRW 2.71 billion in 2023 (down 61.3%), KRW 3.25 billion in 2024 (up 20.0%) and KRW 2.52 billion in 2025 (down 22.7%). Net profit including non-controlling interests was reported at the same amounts in each year.
Total equity at the end of 2025 was KRW 87.4 billion, and the debt ratio stayed between 5.5% and 6.4% over 2022–2025. Operating cash flow was KRW 5.28 billion in 2022, KRW 5.47 billion in 2023, KRW 3.23 billion in 2024 and KRW 4.75 billion in 2025.
Quarterly sales of KRW 7.7 billion in the second quarter of 2026 were the highest of the last five quarters, yet that quarter posted an operating loss of KRW 12.53 million. Operating profit in the third quarter of 2026 was KRW 752 million, a swing to profit, up 248.0% year on year.
However, net loss attributable to controlling shareholders was KRW 1.03 billion in that quarter, a swing into deficit. Net profit attributable to controlling shareholders over the last four quarters totaled KRW 4.81 billion.
Because operating profit and controlling-shareholder earnings moved in opposite directions, the size of non-operating items is the next point to check.